ARWR

Conviction 96HealthcareScan · Mon, Aug 10, 2026

ARWR$88.40+0.86%

ResistanceSupportVol 14Insider sell

Vol MA14 2.32M

May 11May 28Jun 16Jul 6Jul 23Aug 10

ARROWHEAD PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.arrowheadpharma.com ↗

Price88.40

Change+0.86%

Gap-0.95%

Rel volume2.38×

Avg volume2.32M

Avg $ vol192.11M

SMA 2082.53

SMA 5079.98

SMA 20066.68

Price vs 50+10.53%

Price vs 200+32.58%

MA stackbullish

50/200 cross—

Supertrendup · 75.87

RSI (14)59

MACD hist0.31

MACD cross—

Stoch %K / %D49 / 58

ADX (14)27

+DI / −DI29 / 17

RSI divergenceBearish

MACD divergence—

ATR %+4.53%

ADR %4.40%

52w high89.59

52w low16.42

From 52w high-1.33%

Above 52w low+438.37%

New 52w highNo

SqueezeOff

Bollinger width32.17%

%B0.72

Donchian pos72.32%

Donchian high95.49

Donchian low69.88

AVWAP (52w high)87.40

vs AVWAP high+1.15%

AVWAP (52w low)58.37

vs AVWAP low+51.44%

OBV trendUp

Chaikin MF (20)0.02

Today vs 20d2.38×

Avg vol (14d)2.32M

Avg vol (20d)2.32M

Avg $ vol (20d)192.11M

Market cap12.49B

RS 3m (vs SPY)+6.75%

RS 6m (vs SPY)+21.48%

RS line new highNo

Trend template8/8

Technical rank88.3

1 week+2.78%

1 month+15.71%

3 months+21.61%

6 months+37.01%

1 year+450.44%

YTD+30.40%

P/E-7655.97

P/B26.82

P/S15.05

P/FCF79.59

EPS-0.0100

Div yield—

ROE-0.35%

ROA-0.08%

Debt/Eq—

Current5.90

EV/EBITDA103.01

Gross margin—

Net margin-0.20%

Rev growth—

EPS growth99.73%

Price target103.96

Target upside17.60%

Analyst ratingBuy

Institutional94.03%

Ent. value12.42B

Revenue75.25M

Net income-194.28M

Gross profit—

Free cash flow156.89M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out140.86M

Employees711

ListedWed, Feb 1, 1995

Free float134.77M

Float %96.2%

Short interest9.64M

Days to cover4.9d

Short volume63.6%

Squeeze score69 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.36 vs −$1.23

Last surprise-10.6% miss

Setup gradeA+

Conviction96 / 100

Pattern quality—

Tech rank88.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance93.15

Support73.67

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ARWR

All disclosures →

No recent disclosed trades by Congress in ARWR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ARWR · 1 buy · 5 sells

Insider	Side	Shares	Value	Traded	Filed
Cohen Matthew Gregory Director · Common Stock · 2026-06-15	Grant	11.88K	—	2026-06-15	2026-06-17
Lu Hongbo Director · Common Stock · 2026-05-12	Sell	2.97K	$228K	2026-05-12	2026-05-14
Hamilton James C Chief Medical Officer · Common Stock · 2026-04-23	Sell	10K	$750K	2026-04-23	2026-04-24
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22	Sell	8.73K	$628K	2026-04-22	2026-04-24
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22	Sell	1.16K	$82K	2026-04-22	2026-04-24
Apel Daniel Joseph Chief Financial Officer · Common Stock · 2026-04-22	Sell	3.21K	$225K	2026-04-22	2026-04-24

SEC filings

EDGAR filings in ARWR · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.